Hmmm. Medline deal variation to non-exclusive a worry. Obviously it wasn't working. If Medline can't sell this stuff... how will Simavita go with a direct channel to market (competing head-on with Medline!)?
The real question is "why couldn't Medline achieve sales success?". Either they couldn't convey the value to prospective customer targets (a problem) or they could convey the message, but there was insufficient perceived value in the product amongst these same customer targets (an even bigger problem).
Tough road ahead IMO. Definitely a 'wait and see' proposition....because at the moment I don't see much.
-RS
Ann: North American sales and marketing update, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
